METHODS, STATISTICAL FEATURES, AND BASE-LINE RESULTS OF A STANDARDIZED, MULTICENTERED OPHTHALMOLOGIC SURGICAL TRIAL - THE SILICONE STUDY

被引:16
作者
AZEN, SP
BOONE, DC
BARLOW, W
MCCUEN, BW
WALONKER, AF
ANDERSON, MM
LEAN, JS
MOWERY, RL
RYAN, SJ
STERN, W
机构
[1] DUKE UNIV, NEI, DURHAM, NC 27706 USA
[2] UNIV SO CALIF, DEPT OPHTHALMOL, LOS ANGELES, CA 90089 USA
[3] UNIV CALIF SAN FRANCISCO, DEPT OPHTHALMOL, SAN FRANCISCO, CA 94143 USA
[4] GRP HLTH COOPERAT PUGET SOUND, CTR HLTH STUDIES, SEATTLE, WA USA
[5] GRP HLTH COOPERAT PUGET SOUND, DEPT PREVENT MED, SEATTLE, WA USA
[6] GRP HLTH COOPERAT PUGET SOUND, DEPT OPHTHALMOL, SEATTLE, WA USA
来源
CONTROLLED CLINICAL TRIALS | 1991年 / 12卷 / 03期
关键词
CLINICAL TRIAL; SURGICAL TRIAL; OPHTHALMOLOGY; CROSSOVER DESIGN;
D O I
10.1016/0197-2456(91)90022-E
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This article describes the trial design and baseline results for the Silicone Study, a multicenter, randomized surgical trial designed to compare the effectiveness of silicone fluid versus long-acting gas in the treatment of proliferative vitreoretinopathy (PVR). Design features include (1) standardization of the surgical protocol to reduce intersurgeon variability, (2) formulation of a PVR clinical classification system relevant to modern vitreoretinal surgery, and (3) creation of a photographic protocol to document PVR pathology. Statistical issues affecting the analysis of the outcome data include (1) the addition of a second group of patients with more severely diseased eyes after the trial began, (2) the change of a different long-acting gas during the course of the trial, and (3) recurrent retinal detachments that require reoperations with the randomized treatment, and, in some instances, a crossover from the randomized to the alternate treatment. Demographic and baseline ocular characteristics are presented for the two groups under study.
引用
收藏
页码:438 / 455
页数:18
相关论文
共 44 条
[1]   THE RESULTS OF SULFUR-HEXAFLUORIDE GAS IN VITREOUS SURGERY [J].
ABRAMS, GW ;
SWANSON, DE ;
SABATES, WI ;
GOLDMAN, AI .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (02) :165-171
[2]   THE VALIDITY AND RELIABILITY OF PHOTOGRAPHIC DOCUMENTATION OF PROLIFERATIVE VITREORETINOPATHY [J].
AZEN, SP ;
IRVINE, AR ;
DAVIS, MD ;
STERN, W ;
LONN, L ;
HILTON, G ;
SCHWARTZ, A ;
BOONE, D ;
QUILLENTHOMAS, B ;
LYONS, M ;
LEAN, JS .
OPHTHALMOLOGY, 1989, 96 (03) :352-357
[3]  
BARLOW W, IN PRESS CONTROLLED
[4]  
BLUMENKRANZ MS, 1985, ARCH OPHTHALMOL-CHIC, V104, P291
[5]   RESULTS OF SULFUR-HEXAFLUORIDE GAS IN VITREOUS SURGERY [J].
BOURGEOIS, JE ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 96 (03) :405-406
[6]   PERFLUOROPROPANE GAS IN THE MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY [J].
CHANG, S ;
COLEMAN, DJ ;
LINCOFF, H ;
WILCOX, LM ;
BRAUNSTEIN, RA ;
MAISEL, JM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 98 (02) :180-188
[7]  
CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590
[8]  
Cicchetti DV, 1977, APPLIED PSYCHOL MEAS, V1, P195, DOI [DOI 10.1177/014662167700100206, 10.1177/014662167700100206]
[9]  
CONSTABLE IJ, 1974, INVEST OPHTH VISUAL, V13, P627
[10]  
COX MS, 1985, OPHTHALMOLOGY, V93, P646